Company intelligence / Profile preview

Emles Bioventures

London, England, United Kingdomemlesbioventures.com ↗

Ownership: Private
Development stage: Other

Overview

Emles Bioventures is focused on accelerating innovation in the longevity sector by supporting startups, entrepreneurs, and research initiatives that target the biology of aging. The company does not appear to have its own clinical results but rather invests in or incubates projects at various stages related to healthspan extension and age-related disease intervention.

Therapeutic areas: Other
Modalities: Small moleculeBiologic
Industry: Investors

Partnerships

Strategic partnerships with organizations in the longevity space

Beyond the preview

Go deeper on Emles Bioventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emles Bioventures.

Explore the full profile